Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Income Statement [Abstract]
Net Sales	$ 1,924.0	$ 1,929.3	$ 5,798.3	$ 4,939.2
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 581.5	$ 569.4	$ 1,679.5	$ 1,481.0
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 153.7	$ 149.7	$ 463.8	$ 445.0
Research and development	108.9	85.9	383.8	272.0
Selling, general and administrative	802.4	790.0	2,389.9	2,283.9
Goodwill and intangible asset impairment			16.3	645.0
Restructuring and other cost reduction initiatives	23.5	16.2	64.9	89.2
Quality remediation	11.8	9.8	33.0	35.9
Acquisition, integration, divestiture and related	27.3	9.1	66.1	15.7
Operating expenses	1,709.1	1,630.1	5,097.3	5,267.7
Operating Profit (Loss)	214.9	299.2	701.0	(328.5)
Other income, net	0.3	10.6	15.7	17.4
Interest expense, net	(52.6)	(54.0)	(159.6)	(158.9)
Earnings (loss) before income taxes	162.6	255.8	557.1	(470.0)
Provision for income taxes	16.8	9.7	71.1	1.2
Net Earnings (Loss)	145.8	246.1	486.0	(471.2)
Less: Net earnings attributable to noncontrolling interest	0.2	3.6	0.4	1.4
Net Earnings (Loss) of Zimmer Biomet Holdings, Inc.	$ 145.6	$ 242.5	$ 485.6	$ (472.6)
Earnings (Loss) Per Common Share
Basic	$ 0.70	$ 1.17	$ 2.33	$ (2.29)
Diluted	$ 0.69	$ 1.16	$ 2.31	$ (2.29)
Weighted Average Common Shares Outstanding
Basic	208.8	207.1	208.5	206.8
Diluted	210.6	208.5	210.5	206.8